Blog

A study that was published in the January issue of Mayo Clinic proceedings indicated genetic alterations maybe used as a marker in determining higher risk prostate cancer patients. When a man is diagnosed with prostate cancer and it is felt to be lower risk, treatment decisions have to be made between them and their doctor. The publication indicated that genetic markers may be analyzed in these patients to help determine if they should be more aggressive with their treatment or not. This is good news for men’s health and working with their physician.

https://www.mayoclinicproceedings.org/article/S0025-6196(18)30546-9/fulltext